COVID-19 is a contagious disease caused by severe acute respiratory syndrome coronavirus 2.
Symptoms of COVID-19 are variable, but often include fever, cough, fatigue, breathing difficulties, and loss of smell and taste. Symptoms begin one to fourteen days after exposure to the virus. Multi-year studies are underway to further investigate the long-term effects of the disease.
To enhance your search results you can use the various filters available such as mode (online/ on-site).
HIGHLIGHTS OF THE WEBINAR MODULE 1 - Overview of COVID-19, Dr B B Revari (30min) •Microbiology of corona virus, virus history with types and pathophysiology. •Description of t...
IMA Chandigarh welcomes you to recorded webinar session on “Treating Mild to Severe COVID-19 Patients” What was covered: Introduction of panelist: Dr. Mayuri Keskar, MLH & TC4A...
IMA-Karnataka welcomes doctors to this informative recorded session on "Use of Remdesivir in treating patients with COVID-19 (Experience sharing & Updates from Clinical Trials)" Intro...
Recording of the webinar is not available
Remdesivir , is approved in India for the treatment of suspected or laboratory confirmed incidences of COVID-19 in adults and children hospitalized with severe presentations of the disease....
As the incidence of COVID-19 cases continue to rise, we will need multiple approaches to effectively deal with this pandemic. Clinicians are evaluating Favipiravir for use in mild-to-moderat...
Indian Medical Association Rajasthan (IMA Raj) welcomes doctors to view a recorded session on “Clinical & Pulmonary COVID-19 complications” held on 13th Sep 2020, where...
Cases of COVID-19 are steadily rising in India, and because there is limited clinical experience around treatment options it becomes critical to share knowledge. Indian Medical Association Ma...
In India, Remdesivir has been approved for emergency use in patients hospitalized with severe COVID-19. There is a need to understand and share experience on the use of this drug. We welcome you to vi...
The challenges of conducting trials against the backdrop of the COVID-19 pandemic will continue as we collectively journey into the “new normal”. Welcome to the recorded webinar on &...
